Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Blanco

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Seminars in Arthritis and Rheumatism|June 5, 2020
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patientsLucia C Dominguez-Casas, Lara Sánchez-Bilbao, Vanesa Calvo-Río, et al.
Journal of Medical Genetics|September 10, 2016
New insights into the genetic component of non-infectious uveitis through an Immunochip strategyAna Márquez, Miguel Cordero-Coma, José Manuel Martín-Villa, et al.
Journal of Clinical Medicine|August 16, 2020
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter StudyAlba Herrero-Morant, Carmen Álvarez-Reguera, José L Martín-Varillas, et al.
Clinical and Experimental Rheumatology|March 5, 2021
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patientsNuria Vegas-Revenga, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Human Molecular Genetics|February 27, 2014
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortiumMara Colombo, Marinus J Blok, Phillip Whiley, et al.
Breast Cancer Research and Treatment|April 17, 2009
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersRoger L Milne, Ana Osorio, Teresa Ramón y Cajal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in SpainRoger L Milne, Ana Osorio, Teresa Ramón Y Cajal, et al.
Journal of Medical Genetics|April 10, 2016
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samplesJames D Fackenthal, Toshio Yoshimatsu, Bifeng Zhang, et al.
The Lancet. Haematology|June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational studyCarlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
Journal of Clinical Medicine|September 4, 2020
Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 PatientsLara Sánchez-Bilbao, David Martínez-López, Marcelino Revenga, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Seminars in Arthritis and Rheumatism|June 5, 2020
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patientsLucia C Dominguez-Casas, Lara Sánchez-Bilbao, Vanesa Calvo-Río, et al.
Journal of Medical Genetics|September 10, 2016
New insights into the genetic component of non-infectious uveitis through an Immunochip strategyAna Márquez, Miguel Cordero-Coma, José Manuel Martín-Villa, et al.
Journal of Clinical Medicine|August 16, 2020
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter StudyAlba Herrero-Morant, Carmen Álvarez-Reguera, José L Martín-Varillas, et al.
Clinical and Experimental Rheumatology|March 5, 2021
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patientsNuria Vegas-Revenga, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Human Molecular Genetics|February 27, 2014
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortiumMara Colombo, Marinus J Blok, Phillip Whiley, et al.
Breast Cancer Research and Treatment|April 17, 2009
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersRoger L Milne, Ana Osorio, Teresa Ramón y Cajal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in SpainRoger L Milne, Ana Osorio, Teresa Ramón Y Cajal, et al.
Journal of Medical Genetics|April 10, 2016
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samplesJames D Fackenthal, Toshio Yoshimatsu, Bifeng Zhang, et al.
The Lancet. Haematology|June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational studyCarlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
Journal of Clinical Medicine|September 4, 2020
Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 PatientsLara Sánchez-Bilbao, David Martínez-López, Marcelino Revenga, et al.
Pageof 13